Temporal Trends in Incidence and Risk Factors of Congenital Hypothyroidism: Evidence from Population-Based Trend and Matched Case-Control Analyses

Every baby is born with a tiny, unassuming gland in their neck called the thyroid. This gland acts as a master regulator for the body's growth and, most critically, for the development of the brain during the earliest years of life. It produces hormones that guide the construction of neural pathways, ensuring that a child's mind grows as robustly as their body. When a baby is born with congenital hypothyroidism, this gland fails to produce enough of these essential hormones. Without immediate treatment, the lack of hormones can lead to permanent intellectual disability, a tragedy that is entirely preventable if the condition is caught early. Because the signs of this disorder are often invisible at birth, countries around the world have established screening programs to test every newborn's blood for thyroid function. These programs have transformed the outlook for affected children, turning a potential life sentence of disability into a manageable condition treated with daily medication. Yet, despite the success of these screening efforts, the number of babies diagnosed with this condition appears to be rising in many parts of the world, prompting scientists to ask why.

Researchers in northeastern Iran recently set out to understand this rising trend and to identify the specific factors that might be putting certain babies at risk. They focused their investigation on a nine-year period, from 2014 to 2022, analyzing data from a massive national screening program that covers nearly every newborn in the region. The team approached the problem in two complementary ways. First, they looked at the big picture, tracking the number of diagnosed cases year by year to see if the rate was changing over time. Second, they conducted a detailed comparison between two groups of children: 234 infants who had been diagnosed with congenital hypothyroidism and 234 healthy infants who were matched to them by age, sex, and where they lived. By comparing the medical histories, family backgrounds, and birth circumstances of these two groups, the researchers hoped to uncover the specific conditions that made a baby more likely to develop the disorder.

The results of the long-term analysis revealed a clear and steady upward trajectory. Over the nine years of the study, the incidence of congenital hypothyroidism increased significantly, rising by nearly thirty percent each year on average. This was not a sudden spike caused by a change in testing rules or a single bad year; rather, it was a continuous, uninterrupted climb throughout the entire period. The researchers found no specific moment where the trend changed direction, suggesting that the factors driving this increase were persistent and growing in strength over time. This steady rise indicates that while the screening system is working well to find cases, something else is causing more babies to be born with the condition than in previous years.

When the researchers dug into the details of the matched case-control study, they found that several specific factors were strongly linked to the presence of the disorder. One of the most powerful predictors was the mother's health during pregnancy. Babies born to mothers who suffered from high blood pressure while pregnant were far more likely to have congenital hypothyroidism than those whose mothers did not. The study also highlighted the role of genetics; a family history of thyroid problems in close relatives significantly increased a baby's risk. The circumstances of the birth itself mattered as well. Infants delivered via cesarean section were found to be at a higher risk compared to those born vaginally, and babies with a lower birth weight were more likely to be affected. Conversely, the study identified protective factors. Babies born to mothers who had completed a high school diploma were less likely to have the condition, suggesting that education level, which often correlates with better access to healthcare and nutrition, plays a protective role. Interestingly, the study also found that babies born in rural areas had a lower likelihood of the disorder compared to those in urban settings, though the reasons for this difference remain unclear.

The researchers also examined whether the recent global pandemic had played a role, looking specifically at whether mothers who contracted the virus while pregnant were more likely to have a child with the condition. While there was a hint of a connection in the initial data, this link did not hold up when the researchers adjusted for other factors, suggesting it was not a primary driver of the disease. Similarly, while the study noted that the pandemic was a major global event, the data did not support the idea that it was the main cause of the rising numbers. Instead, the evidence points toward a complex mix of biological and environmental factors, including maternal health, family history, and the conditions of the pregnancy itself.

This study provides a crucial snapshot of a public health challenge that is evolving in real time. The steady increase in cases suggests that the current screening programs, while successful at detection, are facing a growing burden of new cases. The findings emphasize that preventing congenital hypothyroidism requires more than just testing babies after they are born; it demands a closer look at the health of mothers before and during pregnancy. By identifying high-risk groups, such as women with high blood pressure or a family history of thyroid issues, doctors can potentially monitor these pregnancies more closely. The study concludes that understanding these patterns is essential for improving care and ensuring that the next generation of children receives the support they need to develop healthy brains and bodies.